Cargando…
The Role of Clonal Hematopoiesis of Indeterminant Potential and DNA (Cytosine-5)-Methyltransferase Dysregulation in Pulmonary Arterial Hypertension and Other Cardiovascular Diseases
DNA methylation is an epigenetic mechanism that regulates gene expression without altering gene sequences in health and disease. DNA methyltransferases (DNMTs) are enzymes responsible for DNA methylation, and their dysregulation is both a pathogenic mechanism of disease and a therapeutic target. DNM...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10650407/ https://www.ncbi.nlm.nih.gov/pubmed/37947606 http://dx.doi.org/10.3390/cells12212528 |
_version_ | 1785135773862854656 |
---|---|
author | Emon, Isaac M. Al-Qazazi, Ruaa Rauh, Michael J. Archer, Stephen L. |
author_facet | Emon, Isaac M. Al-Qazazi, Ruaa Rauh, Michael J. Archer, Stephen L. |
author_sort | Emon, Isaac M. |
collection | PubMed |
description | DNA methylation is an epigenetic mechanism that regulates gene expression without altering gene sequences in health and disease. DNA methyltransferases (DNMTs) are enzymes responsible for DNA methylation, and their dysregulation is both a pathogenic mechanism of disease and a therapeutic target. DNMTs change gene expression by methylating CpG islands within exonic and intergenic DNA regions, which typically reduces gene transcription. Initially, mutations in the DNMT genes and pathologic DNMT protein expression were found to cause hematologic diseases, like myeloproliferative disease and acute myeloid leukemia, but recently they have been shown to promote cardiovascular diseases, including coronary artery disease and pulmonary hypertension. We reviewed the regulation and functions of DNMTs, with an emphasis on somatic mutations in DNMT3A, a common cause of clonal hematopoiesis of indeterminant potential (CHIP) that may also be involved in the development of pulmonary arterial hypertension (PAH). Accumulation of somatic mutations in DNMT3A and other CHIP genes in hematopoietic cells and cardiovascular tissues creates an inflammatory environment that promotes cardiopulmonary diseases, even in the absence of hematologic disease. This review summarized the current understanding of the roles of DNMTs in maintenance and de novo methylation that contribute to the pathogenesis of cardiovascular diseases, including PAH. |
format | Online Article Text |
id | pubmed-10650407 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-106504072023-10-26 The Role of Clonal Hematopoiesis of Indeterminant Potential and DNA (Cytosine-5)-Methyltransferase Dysregulation in Pulmonary Arterial Hypertension and Other Cardiovascular Diseases Emon, Isaac M. Al-Qazazi, Ruaa Rauh, Michael J. Archer, Stephen L. Cells Review DNA methylation is an epigenetic mechanism that regulates gene expression without altering gene sequences in health and disease. DNA methyltransferases (DNMTs) are enzymes responsible for DNA methylation, and their dysregulation is both a pathogenic mechanism of disease and a therapeutic target. DNMTs change gene expression by methylating CpG islands within exonic and intergenic DNA regions, which typically reduces gene transcription. Initially, mutations in the DNMT genes and pathologic DNMT protein expression were found to cause hematologic diseases, like myeloproliferative disease and acute myeloid leukemia, but recently they have been shown to promote cardiovascular diseases, including coronary artery disease and pulmonary hypertension. We reviewed the regulation and functions of DNMTs, with an emphasis on somatic mutations in DNMT3A, a common cause of clonal hematopoiesis of indeterminant potential (CHIP) that may also be involved in the development of pulmonary arterial hypertension (PAH). Accumulation of somatic mutations in DNMT3A and other CHIP genes in hematopoietic cells and cardiovascular tissues creates an inflammatory environment that promotes cardiopulmonary diseases, even in the absence of hematologic disease. This review summarized the current understanding of the roles of DNMTs in maintenance and de novo methylation that contribute to the pathogenesis of cardiovascular diseases, including PAH. MDPI 2023-10-26 /pmc/articles/PMC10650407/ /pubmed/37947606 http://dx.doi.org/10.3390/cells12212528 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Emon, Isaac M. Al-Qazazi, Ruaa Rauh, Michael J. Archer, Stephen L. The Role of Clonal Hematopoiesis of Indeterminant Potential and DNA (Cytosine-5)-Methyltransferase Dysregulation in Pulmonary Arterial Hypertension and Other Cardiovascular Diseases |
title | The Role of Clonal Hematopoiesis of Indeterminant Potential and DNA (Cytosine-5)-Methyltransferase Dysregulation in Pulmonary Arterial Hypertension and Other Cardiovascular Diseases |
title_full | The Role of Clonal Hematopoiesis of Indeterminant Potential and DNA (Cytosine-5)-Methyltransferase Dysregulation in Pulmonary Arterial Hypertension and Other Cardiovascular Diseases |
title_fullStr | The Role of Clonal Hematopoiesis of Indeterminant Potential and DNA (Cytosine-5)-Methyltransferase Dysregulation in Pulmonary Arterial Hypertension and Other Cardiovascular Diseases |
title_full_unstemmed | The Role of Clonal Hematopoiesis of Indeterminant Potential and DNA (Cytosine-5)-Methyltransferase Dysregulation in Pulmonary Arterial Hypertension and Other Cardiovascular Diseases |
title_short | The Role of Clonal Hematopoiesis of Indeterminant Potential and DNA (Cytosine-5)-Methyltransferase Dysregulation in Pulmonary Arterial Hypertension and Other Cardiovascular Diseases |
title_sort | role of clonal hematopoiesis of indeterminant potential and dna (cytosine-5)-methyltransferase dysregulation in pulmonary arterial hypertension and other cardiovascular diseases |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10650407/ https://www.ncbi.nlm.nih.gov/pubmed/37947606 http://dx.doi.org/10.3390/cells12212528 |
work_keys_str_mv | AT emonisaacm theroleofclonalhematopoiesisofindeterminantpotentialanddnacytosine5methyltransferasedysregulationinpulmonaryarterialhypertensionandothercardiovasculardiseases AT alqazaziruaa theroleofclonalhematopoiesisofindeterminantpotentialanddnacytosine5methyltransferasedysregulationinpulmonaryarterialhypertensionandothercardiovasculardiseases AT rauhmichaelj theroleofclonalhematopoiesisofindeterminantpotentialanddnacytosine5methyltransferasedysregulationinpulmonaryarterialhypertensionandothercardiovasculardiseases AT archerstephenl theroleofclonalhematopoiesisofindeterminantpotentialanddnacytosine5methyltransferasedysregulationinpulmonaryarterialhypertensionandothercardiovasculardiseases AT emonisaacm roleofclonalhematopoiesisofindeterminantpotentialanddnacytosine5methyltransferasedysregulationinpulmonaryarterialhypertensionandothercardiovasculardiseases AT alqazaziruaa roleofclonalhematopoiesisofindeterminantpotentialanddnacytosine5methyltransferasedysregulationinpulmonaryarterialhypertensionandothercardiovasculardiseases AT rauhmichaelj roleofclonalhematopoiesisofindeterminantpotentialanddnacytosine5methyltransferasedysregulationinpulmonaryarterialhypertensionandothercardiovasculardiseases AT archerstephenl roleofclonalhematopoiesisofindeterminantpotentialanddnacytosine5methyltransferasedysregulationinpulmonaryarterialhypertensionandothercardiovasculardiseases |